Inactive Instrument

Forest Laboratories, Inc. Share Price

Stocks

End-of-day quote NYSE Other stock markets
- ^USD	-

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
14/04/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
10/04/14	Icahn backs down from demand that eBay spin off PayPal	RE
20/02/14	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/02/14	Icahn says Actavis-Forest deal validates shareholder activism	RE
18/02/14	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
08/01/14	S&P 500 ends flat in wake of Fed minutes	RE
08/01/14	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/01/14	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
23/10/13	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

30/06/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
23/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
20/06/14	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

17/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/04/14	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-2.33%	-2.09%	+49.88%	+169.76%	1,060B
JOHNSON & JOHNSON	-0.82%	-2.30%	+63.79%	+62.56%	619B
ABBVIE INC.	-0.73%	-4.98%	+28.91%	+83.79%	438B
ROCHE HOLDING AG	-0.36%	+1.24%	+30.35%	+25.52%	333B
NOVARTIS AG	-0.28%	-0.80%	+28.69%	+46.69%	282B
ASTRAZENECA PLC	-1.22%	-9.63%	+19.51%	+23.35%	267B
NOVO NORDISK A/S	+0.43%	+0.65%	-27.08%	-38.19%	218B
AMGEN INC.	-0.06%	-2.88%	+23.07%	+61.02%	196B
GILEAD SCIENCES, INC.	-3.72%	-1.10%	+18.41%	+69.98%	161B
Average	-1.00%	-3.33%	+26.17%	+56.05%	397.1B
Weighted average by Cap.	-1.21%	-3.10%	+36.37%	+83.43%

Employees

Sector